These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7777985)

  • 21. Cervico-vaginal fetal fibronectin: predictive value during false labor.
    Langer B; Boudier E; Schlaeder G
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):218-21. PubMed ID: 9093134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fetal fibronectin--biomarker for preterm labour].
    Akush Ginekol (Sofiia); 2010; 49(2):39-42. PubMed ID: 20734676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of interleukin 6 mRNA by RT-PCR in vaginal secretions: association with preterm delivery and neonatal infection in women with preterm labour and intact membranes.
    Goffinet F; Kayem G; Maillard F; Trébéden H; Cabrol D; Weill B; Batteux F
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):167-73. PubMed ID: 15893869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting preterm delivery: the fetal fibronectin test.
    Leeson S; Maresh MJ
    Prof Care Mother Child; 1994 Mar; 4(2):38-9. PubMed ID: 8680158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the fetal fibronectin assay on admissions for preterm labor.
    Joffe GM; Jacques D; Bemis-Heys R; Burton R; Skram B; Shelburne P
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 1):581-6. PubMed ID: 10076132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical usefulness of fetal fibronectin (fFN) expression in cervico-vaginal secretions (CVS)].
    García Alonso LA; Jiménez SG; Ayala Méndez JA; Izquierdo Puente JC; Barahona BE
    Ginecol Obstet Mex; 2002 Aug; 70():379-84. PubMed ID: 12448041
    [No Abstract]   [Full Text] [Related]  

  • 28. [Classification of the risks of premature labor. Implications for treatment].
    Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(2 Suppl):6-9. PubMed ID: 9410929
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fetal fibronectin and preterm birth].
    Luo L; Lü Q; Wei F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):25-6. PubMed ID: 9596866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    McParland PC; Kenyon S; Bell SC; Taylor DJ
    BJOG; 2006 Aug; 113(8):976; author reply 976-7. PubMed ID: 16907946
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rational use of fetal fibronectin in the evaluation of premature labor risk].
    Rozenberg P; Nisand I; Malagrida L; Vayssière C; Goffinet F; Philippe HJ; Tribalat S; Giudicelli Y
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):288-93. PubMed ID: 8767228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Premature labor and fetal fibronectin in cervical and vaginal secretions].
    Lorenz-Eberhardt G; Weiss PA; Haas J; Pürstner P; Adelwöhrer NE
    Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):414-6. PubMed ID: 7926575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal fibronectin.
    Koenn ME
    Clin Lab Sci; 2002; 15(2):96-8, 115. PubMed ID: 12776771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial.
    Grobman WA; Welshman EE; Calhoun EA
    Am J Obstet Gynecol; 2004 Jul; 191(1):235-40. PubMed ID: 15295372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times?
    Lee GT; Burwick R; Zork N; Kjos S
    J Matern Fetal Neonatal Med; 2013 May; 26(7):706-9. PubMed ID: 23170788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions.
    Shimoya K; Hashimoto K; Shimizu T; Saji F; Murata Y
    Am J Obstet Gynecol; 1998 Jul; 179(1):255-6. PubMed ID: 9704795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies.
    Owen P
    Br J Obstet Gynaecol; 1996 Sep; 103(9):937. PubMed ID: 8813321
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibronectin: a predictor of preterm delivery?
    Leeson S; Maresh M
    Br J Obstet Gynaecol; 1993 Apr; 100(4):304-6. PubMed ID: 8494829
    [No Abstract]   [Full Text] [Related]  

  • 40. Fetal fibronectin and the safety of outpatient management of preterm labor symptoms.
    Plaut M
    Am J Obstet Gynecol; 1996 Feb; 174(2):797-8. PubMed ID: 8623827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.